Atanasio
Pandiella Alonso
Hospital Clinic Barcelona
Barcelona, EspañaPublicacións en colaboración con investigadores/as de Hospital Clinic Barcelona (6)
2021
-
Modelling hypersensitivity to trastuzumab defines biomarkers of response in HER2 positive breast cancer
Journal of Experimental and Clinical Cancer Research, Vol. 40, Núm. 1
2017
2016
2012
-
Clinical significance of CD81 expression by clonal plasma cells in high-risk smoldering and symptomatic multiple myeloma patients
Leukemia, Vol. 26, Núm. 8, pp. 1862-1869
2005
-
Bortezomib is an efficient agent in plasma cell leukemias
International Journal of Cancer, Vol. 114, Núm. 4, pp. 665-667
-
Genetic abnormalities and patterns of antigenic expression in multiple myeloma
Clinical Cancer Research, Vol. 11, Núm. 10, pp. 3661-3667